SAINT LAURENT, Quebec, Dec. 18, 2023 IntelGenx Corp. today announced that it has entered into development and license agreements with a wholly-owned subsidiary of Covenant Animal Health.
IntelGenx Receives Approval to Conduct MONTPARK Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson s Disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
06.11.2023 - IntelGenx to Manufacture and Supply Three New Filmstrip Products: CBD20, THC10, and THC10:CBD10SAINT LAURENT, Quebec, Nov. 06, 2023 (GLOBE NEWSWIRE) - IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the Company or IntelGenx ) today announced that it and .